PECAM1 and cerebral malaria: Although there are challenges in reporting precise molecular characterization in the nature of BBB damage in human cerebral malaria [51], this assertion that CD31 could play a role in cerebral malaria has been demonstrated by the association of CD31 polymorphisms with susceptibility to cerebral malaria [52].